drugset / Trial / NCT04491916

Iron Therapy in Patients With End-Stage Renal Disease

NCT04491916

NaSingle-groupOpen-labelTreatment

Summary

This study will compare the clinical outcome of patients with maintenance dialysis room after changing the iron treatment guidelines from original upper limit with ferritin\>500ng/ml, or TSAT\>20% to Ferritin\> 800ng / ml, or TSAT\> 50%.

Timeline

Start
2020-04-01
Primary completion
2022-12-31
Completion
2022-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Iron sucrose Unknown 100 mg